Stimcell Energetics (STME) Other Non Operating Income (2016 - 2026)
Stimcell Energetics' (STME) quarterly Other Non Operating Income came in at $30146.0 in Q1 2026, down 43.15% year-on-year from $53027.0 in Q1 2025, and up 1604.13% quarter-over-quarter from $1769.0 in Q3 2025.
Stimcell Energetics (STME) Other Non Operating Income (2016 - 2026) Analysis & Trends
Stimcell Energetics' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $30146.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 43.15% year-over-year to $30146.0 in Q1 2026; TTM through Feb 2026 was -$55077.0, a 75.27% increase from a year earlier, with the FY2025 full-year figure at $13047.0, up 284.23% from the prior year.
- Other Non Operating Income grew to $30146.0 in Q1 2026 per STME's latest filing, from $1769.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $187517.0 in Q1 2024 and bottomed at -$206428.0 in Q2 2024.
- The 5-year median for Other Non Operating Income is $3589.0 (2023), against an average of $737.86.
- Across the five-year window, Other Non Operating Income soared 124.2% in 2022 and sank 890.87% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $48200.0 in 2022, then plunged by 86.68% to $6420.0 in 2023, then sank by 890.87% to -$50774.0 in 2024, then surged by 103.48% to $1769.0 in 2025, then surged by 1604.13% to $30146.0 in 2026.
- Per Business Quant, the three latest STME Other Non Operating Income figures stand at $30146.0 (Q1 2026), $1769.0 (Q3 2025), and -$86992.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 30,146.00 |
| Aug 31, 2025 | 1,769.00 |
| May 31, 2025 | -86,992.00 |
| Feb 28, 2025 | 53,027.00 |
| Nov 30, 2024 | -50,774.00 |
| Aug 31, 2024 | -18,521.00 |
| May 31, 2024 | -206,428.00 |
| Feb 29, 2024 | 187,517.00 |
| Nov 30, 2023 | 6,420.00 |
| Aug 31, 2023 | 5,409.00 |
| Nov 30, 2022 | 48,200.00 |
| Aug 31, 2022 | 58,994.00 |
| May 31, 2022 | -6,665.00 |
| Feb 28, 2022 | -11,772.00 |
| Nov 30, 2021 | 21,499.00 |
| Aug 31, 2021 | 64,269.00 |
| May 31, 2021 | -68,463.00 |
| Feb 28, 2021 | -26,786.00 |
| Nov 30, 2020 | -7,227.00 |
| Aug 31, 2020 | -56,882.00 |